Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier
Open accessThe DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Abstract
Protective mucus coatings typically trap and rapidly remove foreign particles from the eyes, gastrointestinal tract, airways, nasopharynx, and female reproductive tract, thereby strongly limiting opportunities for controlled drug delivery at mucosal surfaces. No synthetic drug delivery system composed of biodegradable polymers has been shown to penetrate highly viscoelastic human mucus, such as non-ovulatory cervicovaginal mucus, at a significant rate. We prepared nanoparticles composed of a biodegradable diblock copolymer of poly(sebacic acid) and poly(ethylene glycol) (PSA-PEG), both of which are routinely used in humans. In fresh undiluted human cervicovaginal mucus (CVM), which has a bulk viscosity approximately 1,800-fold higher than water at low shear, PSA-PEG nanoparticles diffused at an average speed only 12-fold lower than the same particles in pure water. In contrast, similarly sized biodegradable nanoparticles composed of PSA or poly(lactic-co-glycolic acid) (PLGA) diffused at least 3,300-fold slower in CVM than in water. PSA-PEG particles also rapidly penetrated sputum expectorated from the lungs of patients with cystic fibrosis, a disease characterized by hyperviscoelastic mucus secretions. Rapid nanoparticle transport in mucus is made possible by the efficient partitioning of PEG to the particle surface during formulation. Biodegradable polymeric nanoparticles capable of overcoming human mucus barriers and providing sustained drug release open significant opportunities for improved drug and gene delivery at mucosal surfaces.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oral application of OVA-loaded PLGA nanospheres, which were further coated with PEG to reduce particle aggregation and to enhance particulate blood circulation [78], initiated a high OVA-specific IgG response at very low allergen amounts (5 μg).”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [78]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Designing materials for biology and medicine
Langer, R., & Tirrell, D. A. (2004) · Nature · doi:10.1038/nature02388 · Cited by 3,198 · cited 1×
“In addition to rapid penetration of mucus fluids, important attributes of a desirable polymeric platform for mucosal drug delivery include efficient drug loading and sustained release upon exposure to water (41).”
BackgroundBiodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815 · cited 5×
“Encapsulation of drugs and genes in polymeric particles offers the potential for localized and sustained delivery to mucosal tissues (1, 2).”
BackgroundSelf-citationTargeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,663 · cited 1×
“Using these polymers, we formulated nanoparticles with an average hydrodynamic diameter of 173 nm (Table 1) using a conventional solvent diffusion method where the continuous phase was water (19).”
MethodMicro- and macrorheology of mucus
Lai, S. K., Wang, Y.-Y., Wirtz, D., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.012 · Cited by 1,223 · cited 1×
“We further tested the ability of biodegradable PSA-PEG particles to penetrate fresh, undiluted sputum expectorated from cystic fibrosis (CF) patients, which has a bulk viscosity typically approximately 104- to 105-fold higher than that of water under low shear (compared to 103-fold for mucus from healthy volunteers) (…”
BackgroundSelf-citationMatsui, H., Grubb, B. R., Tarran, R., Randell, S. H., Gatzy, J. T., Davis, C. W., & Boucher, R. C. (1998) · Cell · doi:10.1016/s0092-8674(00)81724-9 · Cited by 1,169 · cited 1×
“By using the Fick diffusion model and a sputum layer thickness of approximately 10 m (the thickness of sputum is decreased due to dehydration of airway mucus secretions and collapse of the periciliary layer from the imbalanced ion transport in CF) (26), we again expect significant fractions of biodegradable PSA-PEG na…”
MethodMucus clearance as a primary innate defense mechanism for mammalian airways
Knowles, M. R., & Boucher, R. C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215217 · Cited by 1,054 · cited 1×
“The reported diffusion coefficient for latex nanoparticles ranging in size from 59–1,000 nm is 0 m2/s in human cervical mucus (7); particles trapped in this manner are typically cleared from mucosal surfaces within seconds to a few hours depending on anatomical site (3, 8, 9).”
BackgroundRapid transport of large polymeric nanoparticles in fresh undiluted human mucus
Lai, S. K., O'Hanlon, D. E., Harrold, S., Man, S. T., Wang, Y.-Y., Cone, R., & Hanes, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608611104 · Cited by 1,050 · cited 10×
“We have recently discovered that densely coating nonbiodegradable latex particles with PEG, a hydrophilic and uncharged molecule, effectively minimizes adhesive interactions between nanoparticles and mucins (13), thereby allowing nanoparticles to rapidly penetrate highly viscoelastic human mucus by moving through open…”
BackgroundMethodResultSelf-citation
Research works printed but not linked: 1
- RA Cone, Mucus. Mucosal Immunology, eds PL Ogra, ME Lamm, W Strober, JR McGhee, J Mestecky, J Bienenstock (Academic, 3 Ed, San Diego), pp. 43–64 (1999).
Cited by
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
“Importantly, numerous methods for producing biodegradable NPs with sufficiently dense PEG coatings for rapid penetration through human CVM have been described [133, 136-138], providing an array of options for developing NP-based therapies for more efficacious vaginal drug delivery.”
Self-citationBiomedical applications of biodegradable polymers
Ulery, B. D., Nair, L. S., & Laurencin, C. T. (2011) · Journal of Polymer Science Part B: Polymer Physics · doi:10.1002/polb.22259 · Cited by 2,206
Nanoparticle PEGylation for Imaging and Therapy
Jokerst, J. V., Lobovkina, T., Zare, R. N., & Gambhir, S. S. (2011) · Nanomedicine · doi:10.2217/nnm.11.19 · Cited by 2,046
“However, there are many other PEGylated polymers for making drug-containing NPs, including polylactic acid [79], poly(hexadecylcyanoacrylate) (PHDCA) [21], polycaprolactone [80], chitosan [81] and poly(sebacic acid) [82].”
BackgroundOral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
Ensign, L. M., Cone, R., & Hanes, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,623
“This mucoinert coating has been translated to engineering biodegradable nanoparticles [8], nanoparticles capable of penetrating highly viscoelastic cystic fibrosis sputum [7], and biodegradable particles composed entirely of “generally regarded as safe” (GRAS) ingredients [10].”
BackgroundSelf-citationAnselmo, A. C., & Mitragotri, S. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10003 · Cited by 1,321
“Interestingly, recent preclinical work has highlighted advantages of PEGylated particles beyond extended circulation, notably their diffusion in tissues(118) and their abilities to pass through tight biological barriers.(36,119) It is possible that clinically used PEGylated particles have benefitted from these effects.”
Background
Metadata
- Authors
- Tang, B. C., Dawson, M., Lai, S. K., Wang, Y.-Y., Suk, J. S., Yang, M., Zeitlin, P., Boyle, M. P., Fu, J., & Hanes, J.
- Affiliations
- Johns Hopkins University (US)
- Georgia Institute of Technology (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-11-17
- Volume
- 106
- Issue
- 46
- Pages
- 19268-19273
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2780804
- OpenAlex
- W2071026997
- Cited by
- 453
- References
- 47
- Citations by year
- 2026: 15 · 2025: 17 · 2024: 16 · 2023: 22 · 2022: 20 · 2021: 25 · 2020: 31 · 2019: 26 · 2018: 33 · 2017: 40 · 2016: 33 · 2015: 31 · 2014: 35 · 2013: 29 · 2012: 33
- FWCI
- 18.18
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R21HL089816)
- National Cancer Institute (R01CA140746)
- National Center for Research Resources (UL1RR025005)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- mucus penetration, biodegradable polymer nanoparticles, cervicovaginal mucus, polyethylene glycol, poly(lactic-co-glycolic acid), mucus viscosity, nanoparticle diffusion, sputum, cystic fibrosis, mucosal drug delivery, sustained drug release
- MeSH terms
- Anhydrides, Cervix Mucus, Cystic Fibrosis, Drug Carriers, Female, Humans, Polyethylene Glycols, Sputum, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier. https://app.cochat.ai/papers/10.1073/pnas.0905998106
- The paper
- Tang, B. C., Dawson, M., Lai, S. K., Wang, Y.-Y., Suk, J. S., Yang, M., Zeitlin, P., Boyle, M. P., Fu, J., & Hanes, J. (2009). Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0905998106
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.